Ippei Kanazawa

Serum Osteocalcin Level Is Associated with Glucose Metabolism and Atherosclerosis Parameters in Type 2 Diabetes Mellitus

Ippei Kanazawa, Toru Yamaguchi, Masahiro Yamamoto et al. · The Journal of Clinical Endocrinology & Metabolism · 2008 · 414 citations · Full text

Serum undercarboxylated osteocalcin was inversely associated with plasma glucose level and fat mass in type 2 diabetes mellitus

Ippei Kanazawa, Toru Yamaguchi, Mika Yamauchi et al. · Osteoporosis International · 2010 · 242 citations

Metabolic Syndrome, Health Sciences, Physiology +9

Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression

Ippei Kanazawa, Toru Yamaguchi, Shozo Yano et al. · Biochemical and Biophysical Research Communications · 2008 · 227 citations

Amp Kinase Activation, Bone Morphogenic Protein, Bone Metabolism +9

Effects of high glucose and advanced glycation end products on the expressions of sclerostin and RANKL as well as apoptosis in osteocyte-like MLO-Y4-A2 cells

Ken-ichiro Tanaka, Toru Yamaguchi, Ippei Kanazawa et al. · Biochemical and Biophysical Research Communications · 2015 · 172 citations

Sclerostin, High Glucose, Bone Morphogenic Protein +12

Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cells

Ippei Kanazawa, Toru Yamaguchi, Shozo Yano et al. · BMC Cell Biology · 2007 · 169 citations · Full text